Skip to main navigation Skip to search Skip to main content

Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype

  • Sandra van Wilpe
  • , Donjetë Simnica
  • , Peter Slootbeek
  • , Thomas van Ee
  • , Samhita Pamidimarri Naga
  • , Mark A.J. Gorris
  • , Lieke L. van der Woude
  • , Shabaz Sultan
  • , Rutger H.T. Koornstra
  • , Inge M. van Oort
  • , Winald R. Gerritsen
  • , Leonie I. Kroeze
  • , Michiel Simons
  • , Geert J.L.H. van Leenders
  • , Mascha Binder
  • , I. Jolanda M. de Vries
  • , Niven Mehra*
  • *Corresponding author for this work
  • Radboud University Medical Center
  • Radboud Institute for Molecular Life Sciences - RIMLS
  • Martin Luther University Halle-Wittenberg
  • Oncode Institute (Nederland)
  • Rijnstate Hospital

Research output: Contribution to journalArticleAcademicpeer-review

10 Citations (Scopus)
100 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology